Cancer intervention and prevention company Check Cap is developing new, low-invasive ingestible capsule technology that aims to address issues associated with preventive screenings for colon cancer.
The C-Scan capsule does not require bowel preparation and it offers a more patient-friendly option than colonoscopy to detect the precursors of colorectal cancer before they progress. The technology is planned to be evaluated in a study in the U.S. in a few months, and if approved, it could be available to patients in a few years.
The ingestible capsule uses a series of x-rays as it moves through the digestive track to identify polyps, recording data in real time. The capsule could be ingested in a health practitioners’ office without the need for patients to travel to a hospital and the capsule moves through the digestive track as patients go through their daily routine.
The capsule technology seeks to curb preventive-screening scheduling delays due to COVID, invasiveness, and the procedure prep that is required of patients.
Yoav Kimchy, PhD, inventor of the technology and former navy officer, was inspired by submarines as the basis for the technology.
Featured image: The capsule technology seeks to curb preventive-screening scheduling delays for colon cancer. Photo: Check Cap